CDC asks, What if a credible Dengue vaccine candidate emerges?
Posted Feb 17 2012 12:00am
What if a credible Dengue vaccine candidate emerges in the not too distant future? After all, a number of research units are hard at work in a spirited race to be the first to market one. Some teams are getting close too. They have even begun human trials so this is not exactly a pipe dream.
When happens then when a vaccine is eventually approved? No doubt, the question of availability will arise: Will those who need it most be able to get it?
The Centers for Disease Control (CDC) and Dengue experts have their eyes on this issue. Recently, they had a meeting in Puerto Rico during which they sought to develop a slate of guidelines to govern the introduction of licensed Dengue vaccines unto the market.
According to the CDC website, the objectives of the Dengue v2V (Vaccine to Vaccination) international meeting was the documentation of “…the human and economic impact of dengue; providing guidance regarding vaccine adoption strategies based on clinical, epidemiologic, other technical data; and making recommendations about the introduction of a dengue vaccine for routine and catch-up immunization.”
The CDC had better hurry because a credible vaccine candidate will most likely become available this decade.